Real-time enrollment status for this hematopoietic and lymphoid system neoplasm clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 1:13 PM UTC
| NCT Number | NCT06022965 |
| Recruiting Status | Recruiting |
| Condition | Hematopoietic and Lymphoid System Neoplasm |
| Phase | Clinical Trial |
| Target Enrollment | 216 participants |
| Active Locations | 3 sites in the US |
| Sponsor | City of Hope Medical Center |
| Last Updated on CT.gov | October 6, 2025 (Oct 6, 2025) |
As of July 13, 2026: Clinical trial NCT06022965 is currently recruiting participants. This clinical trial study for hematopoietic and lymphoid system neoplasm is actively seeking new participants at 3 locations across the United States. The study is sponsored by City of Hope Medical Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06022965 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06022965 was last updated Oct 6, 2025 (October 6, 2025). HelloStudys verifies this status automatically.